• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).

作者信息

Galadanci Najibah A, Umar Abdullahi Shehu, Vance Leah D, Musa Tabari Abdulkadir, Ali Shehi, Belonwu Raymond, Salihu Auwal, Amal Galadanci Aisha, Wudil Jibir Binta, Bello-Manga Halima, Neville Kathleen, Kirkham Fenella J, Shyr Yu, Phillips Sharon, Covert Brittany V, Kassim Adetola A, Jordan Lori C, Aliyu Muktar H, DeBaun Michael R

出版信息

Am J Hematol. 2018 Mar;93(3):E83. doi: 10.1002/ajh.25012. Epub 2018 Feb 2.

DOI:10.1002/ajh.25012
PMID:29411418
Abstract
摘要

相似文献

1
Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).尼日利亚镰状细胞贫血患儿原发性卒中预防可行性试验（SPIN试验）。
Am J Hematol. 2018 Mar;93(3):E83. doi: 10.1002/ajh.25012. Epub 2018 Feb 2.
2
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.输血预防镰状细胞病患者的原发性和继发性中风
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD003146. doi: 10.1002/14651858.CD003146.pub3.
3
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.镰状细胞病患者无症状性脑梗死的预防干预措施。
Cochrane Database Syst Rev. 2017 May 13;5(5):CD012389. doi: 10.1002/14651858.CD012389.pub2.
4
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.输血预防镰状细胞病患者的原发性和继发性中风
Cochrane Database Syst Rev. 2013 Nov 14(11):CD003146. doi: 10.1002/14651858.CD003146.pub2.
5
Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).尼日利亚镰状细胞贫血患儿原发性卒中预防可行性试验（SPIN试验）
Am J Hematol. 2017 Aug;92(8):780-788. doi: 10.1002/ajh.24770. Epub 2017 Jun 15.
6
The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.儿童镰状细胞病的一级卒中预防的临床效果和成本效益：系统评价和经济评估。
Health Technol Assess. 2012;16(43):1-129. doi: 10.3310/hta16430.
7
Blood transfusion for preventing stroke in people with sickle cell disease.输血预防镰状细胞病患者中风
Cochrane Database Syst Rev. 2002(1):CD003146. doi: 10.1002/14651858.CD003146.
8
Impact of Food Insecurity on Malnutrition Treatment Response in Nigerian Children With Sickle Cell Anemia and Severe Acute Malnutrition.粮食不安全对尼日利亚镰状细胞贫血和重度急性营养不良儿童营养不良治疗反应的影响
Pediatr Blood Cancer. 2025 Jun;72(6):e31637. doi: 10.1002/pbc.31637. Epub 2025 Mar 10.
9
Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.尼日利亚镰状细胞病儿童的一级卒中预防（SPIN）：开展可行性试验的挑战。
Pediatr Blood Cancer. 2015 Mar;62(3):395-401. doi: 10.1002/pbc.25289. Epub 2014 Nov 14.
10
Capacity Building for Primary Stroke Prevention Teams in Children Living With Sickle Cell Anemia in Africa.非洲镰状细胞贫血儿童初级卒中预防团队的能力建设。
Pediatr Neurol. 2021 Dec;125:9-15. doi: 10.1016/j.pediatrneurol.2021.08.010. Epub 2021 Sep 4.

引用本文的文献

1
Transcranial Doppler ultrasound velocities in a population of unstudied African children with sickle cell anemia.未进行过相关研究的非洲镰状细胞贫血儿童群体的经颅多普勒超声速度
EJHaem. 2023 Nov 29;5(1):3-10. doi: 10.1002/jha2.818. eCollection 2024 Feb.
2
Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample.乌干达镰状细胞贫血儿童的脑磁共振成像和血管造影：横断面研究。
J Stroke Cerebrovasc Dis. 2022 Apr;31(4):106343. doi: 10.1016/j.jstrokecerebrovasdis.2022.106343. Epub 2022 Feb 11.
3
The V-RAMP Program: Building Research Administration and Management Capacity in Nigeria.
V-RAMP 项目：提升尼日利亚的研究管理与行政能力
J Glob Health Rep. 2021;5. doi: 10.29392/001c.24355. Epub 2021 Jun 6.
4
The V-BRCH Project: building clinical trial research capacity for HIV and noncommunicable diseases in Nigeria.V-BRCH 项目：在尼日利亚建立艾滋病毒和非传染性疾病临床试验研究能力。
Health Res Policy Syst. 2021 Mar 10;19(1):32. doi: 10.1186/s12961-020-00656-z.
5
Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial.撒哈拉以南非洲儿童镰状细胞贫血症的一级预防：III 期随机临床试验的原理和设计。
Pediatr Hematol Oncol. 2021 Feb;38(1):49-64. doi: 10.1080/08880018.2020.1810183. Epub 2020 Nov 25.
6
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.输血预防镰状细胞病患者的原发性和继发性中风。
Cochrane Database Syst Rev. 2020 Jul 27;7(7):CD003146. doi: 10.1002/14651858.CD003146.pub4.
7
COVID-19 and SCA: an old friend comes to the rescue.COVID-19 和 SCA：老朋友前来救援。
Blood. 2020 May 28;135(22):1925-1926. doi: 10.1182/blood.2020006442.
8
Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.在 COVID-19 大流行期间，为 SCA 患儿启动预防中风的辅助低剂量羟基脲治疗。
Blood. 2020 May 28;135(22):1997-1999. doi: 10.1182/blood.2020005992.
9
Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria.羟脲在尼日利亚中北部乔斯治疗镰状细胞贫血儿童的疗效和安全性。
J Trop Pediatr. 2020 Jun 1;66(3):290-298. doi: 10.1093/tropej/fmz070.